News | Business
20 Jan 2018 21:56
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • Days of Xmas
  • News
  • Sport
  • Weather
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • Crime.co.nz
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Business

    Pacific Edge gets $3m extension to grant

    Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.

    21 March 2017

    Pacific Edge has won a two-year extension to its Callaghan Innovation research grant to fund the development of its Cxbladder diagnostic suite of products for bladder cancer detection.

    The Dunedin-based firm has received up to $3 million of extra funding for research and development spread over two years, on top of an initial three-year grant of $4.5m it received in 2014, it said in a statement.

    Since the first grant was awarded, Pacific Edge has launched three new products to add to the original bladder cancer diagnostics test, with each test addressing different clinical needs.

    The shares rose 3.5 per cent to 59 cents.

    "Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients," chief executive David Darling said.

    "The Growth Grant supplements Pacific Edge's own investment into R&D and will enable us to bring new innovations through into new products and product improvements."

    The company raised $8 million in February through a share placement to institutional investors to shore up its balance sheet as it ramps up efforts to lift commercial growth.

    It started making commercial sales in 2013 and at the time was targeting $100m in gross revenue within five years.

    The recent capital raise left it with $9m of cash to fund its immediate growth needs, and when reporting its first half result in November it signalled plans to have all four Cxbladder products fully launched in the US by 2018.

    # (BusinessDesk receives funding from Callaghan Innovation to help cover the commercialisation of innovation.)


    NZN




    © 2018 NZN, NZCity


     Other Business News
     20 Jan: Business booming for Indonesia's 'sharia motorbike taxis'
     20 Jan: Dotcom suing NZ govt for 'billions'
     20 Jan: Inflation data not expected to surprise
     20 Jan: Partners sought for Northcote Development
     20 Jan: Genetics and breeding experts coming to NZ
     19 Jan: Cricketer sentenced to community work
     19 Jan: Trustpower affirms solid earnings guidance
     Top Stories

    RUGBY RUGBY
    Liam Messam signs for Toulon More...


    BUSINESS BUSINESS
    Business booming for Indonesia's 'sharia motorbike taxis' More...



     Today's News

    Cricket:
    NZ U19s trump South Africa at World Cup 21:36

    Tennis:
    Daniell through to Aust Open third round 20:36

    Cycling:
    Bibby wins Cycle Classic fourth stage 19:26

    Technology:
    Rocket Lab forced to abort launch again 19:06

    Golf:
    Fox improves standing in Abu Dhabi golf 18:16

    Law and Order:
    Man charged over fatal Northland fight 17:36

    Sports:
    Coll progresses in NYC squash tournament 17:16

    Auckland:
    Newmarket Plaza fire extinguished 16:36

    Hockey:
    Black Sticks fall to India, out of final 16:36

    International:
    Pope car's flat tyre prompts elaborate security operation 14:56


     News Search






    Power Search


    © 2018 New Zealand City Ltd